Breast Cancer Hope

Cardiff Medical @ Cardiff University

Breast Cancer Hope provided a grant of £29000 to Cardiff-China medical research collaborative Unit at Cardiff University to support molecular science research in the field of breast cancer including the role of the immune system in fighting breast cancer.

Telomerase Control - Journal Oncotarget

Breast Cancer Hope provided a grant of £100,000 to sponsor Dr Hanna Linne to complete a PhD thesis at Brunel Institute of cancer genetics and pharmacogenomics in the field of telomerase control. The key paper from the thesis was published in highly regarded Journal Oncotarget and the findings enhance our understanding of cancer and opened new avenues for cancer treatment research

University College London and Royal Free Hospital

Breast Cancer Hope provided a grant of £46,000 to UCL and Royal Free Hospital to support recruitment to the International Breast Genome Cohort. This is a collaborative platform that will collect clinical and germline as well as Tumour DNA from breast cancer patients of non-European origin. The focus of this effort is to improve diversity in genomic research and shed further light on factors that affect cancer outcome inequalities.

Cardiff Medical @ Cardiff University

Breast Cancer Hope provided a donation of £121,863.00 to fully fund a UK home based PhD studentship in Cardiff University's Cardiff-China Medical Research Collaborative.
The PhD thesis will explore the prospective clinical, prognostic and therapeutic value of the disialoganglioside GD2 molecule in breast cancer.
The studentship will endeavour to establish links between GD2 and clinical breast cancer, mapping mechanisms of its actions and scoping its potential value for targeting therapeutics.

Breast Cancer Hope Report – Summer 2025

The Breast Cancer Hope Report – Summer 2025 shares the latest updates from Niamh O’Neill’s PhD research, supported by Breast Cancer Hope. The report highlights progress in investigating GD2, a molecule linked to aggressive breast cancers, and explores how targeting its biosynthesis could lead to more effective, less toxic treatments. It also showcases international collaborations, conference presentations, and the impact of donor support in advancing research with real potential to improve outcomes for breast cancer patients. Download the full report (PDF).